FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis

News

Date: 28th Mar, 2025 Source: N/A Country: N/A Original Source

Brief

"On March 28, 2025, the Food and Drug Administration (FDA) issued an update regarding FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis. The Visby Medical Women's Sexual Health Test is a single-use, at-home test that can be purchased without a prescription and delivers results in approximately 30 minutes, correctly identifying 97-100% of positive and negative samples."

This content is restricted.

Highlights content goes here...

This content is restricted.

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis

Brief

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.